SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (2773)5/16/1999 11:53:00 PM
From: Ed Ajootian  Read Replies (1) of 10280
 
Peter,

Do you or any other serious SEPR fans know if any of SEPR's other deals with the pharma's have terms similar to this Nori deal, where the other party can back out and just take royalties?

It would seem to me that a term such as that which J&J took advantage of in backing out of the Nori deal is very significant. Terms such as this should be disclosed to shareholders, in the same press release that announces the deal itself --- we shouldn't have to go wading through the actual contract to ferret this stuff out.

IMO SEPR management has a serious credibility problem here. What other "gotchas" are included in their other deals that they haven't told us about?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext